Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers
Condition: Healthy Volunteers Interventions: Drug: AZD9833; Drug: Midazolam; Drug: Omeprazole; Drug: Dabigatran Etexilate; Drug: Celecoxib Sponsor: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2022 Category: Research Source Type: clinical trials
Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants
Conditions: Cushing Syndrome; Neoplasms Interventions: Drug: Dabigatran Etexilate; Drug: Relacorilant Sponsor: Corcept Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2022 Category: Research Source Type: clinical trials